LeMaitre Vascular Inc LMAT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:03 PM EDT
75.90UNCH (UNCH)
Volume
3,910
Close
75.90quote price arrow up+0.90 (+1.20%)
Volume
249,959
52 week range
44.27 - 76.24
Loading...
  • Open75.32
  • Day High76.19
  • Day Low74.21
  • Prev Close75.00
  • 52 Week High76.24
  • 52 Week High Date05/06/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.704B
  • Shares Out22.45M
  • 10 Day Average Volume0.18M
  • Dividend0.64
  • Dividend Yield0.84%
  • Beta0.87
  • YTD % Change33.72

KEY STATS

  • Open75.32
  • Day High76.19
  • Day Low74.21
  • Prev Close75.00
  • 52 Week High76.24
  • 52 Week High Date05/06/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23
  • Market Cap1.704B
  • Shares Out22.45M
  • 10 Day Average Volume0.18M
  • Dividend0.64
  • Dividend Yield0.84%
  • Beta0.87
  • YTD % Change33.72

RATIOS/PROFITABILITY

  • EPS (TTM)1.51
  • P/E (TTM)50.28
  • Fwd P/E (NTM)44.05
  • EBITDA (TTM)50.438M
  • ROE (TTM)11.65%
  • Revenue (TTM)199.887M
  • Gross Margin (TTM)66.45%
  • Net Margin (TTM)16.99%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date05/15/2024
  • Div Amount0.16
  • Split Date-
  • Split Factor-

Latest On LeMaitre Vascular Inc

 

Profile

MORE
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue...
George LeMaitre
Chairman of the Board, Chief Executive Officer
David Roberts
President, Director
Joseph Pellegrino Jr.
Chief Financial Officer, Director
Giovannella Deiure
Vice President - Sales, Southern Europe
Helen Goulding
Vice President - Sales, Northern Europe
Address
63 2nd Ave
Burlington, MA
01803-4413
United States

Top Peers

SYMBOLLASTCHG%CHG
ESTA
Establishment Labs Holdings Inc
53.94-0.44-0.81%
FNA
Paragon 28 Inc
10.53-0.14-1.31%
CTKB
Cytek Biosciences Inc
6.38-0.04-0.62%
SILK
Silk Road Medical Inc
20.56-0.34-1.63%
TMCI
Treace Medical Concepts Inc
11.12-0.09-0.80%